Lazcluze

Active Ingredient(s): Lazertinib Mesylate
FDA Approved: * August 19, 2024
Pharm Company: * JANSSEN BIOTECH
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Lazcluze 80 mg Oral Tablet, Film Coated
NDC: 57894-080
Labeler:
Janssen Biotech, Inc.
Lazcluze 240 mg Oral Tablet, Film Coated
NDC: 57894-240
Labeler:
Janssen Biotech, Inc.